1. The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?

   • Manfredi Rizzo
   • Ali A. Rizvi
   • Kaspar Berneis

   Review Article 17 October 2008 Pages: 1 - 11

   

2. Comprehensive genetic analysis of the dipeptidyl peptidase-4 gene and cardiovascular disease risk factors in obese individuals

   • Luigi Bouchard
   • Geneviève Faucher
   • Marie-Claude Vohl

   Original Article 06 August 2008 Pages: 13 - 21

   

3. Ophthalmoplegia in diabetes mellitus: a retrospective study

   • Domenico Greco
   • Francesco Gambina
   • Filippo Maggio

   Original Article 29 August 2008 Pages: 23 - 26

4. Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes

   • Sudarshan K. Vijay
   • Manish Mishra
   • K. Tripathi

   Original Article 29 August 2008 Pages: 27 - 33

   

5. Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control

   • Simona I. Chisalita
   • Torbjörn Lindström
   • Hans J. Arnqvist

   Original Article 06 September 2008 Pages: 35 - 42

   

6. Genetic variations in the pancreatic ATP-sensitive potassium channel, β-cell dysfunction, and susceptibility to type 2 diabetes

   • D. A. Chistiakov
   • V. A. Potapov
   • V. V. Nosikov

   Original Article 29 August 2008 Pages: 43 - 49

7. A single test procedure to diagnose gestational diabetes mellitus

   • C. Anjalakshi
   • V. Balaji
   • V. Seshiah

   Original Article 02 October 2008 Pages: 51 - 54

   

8. Glycaemic variability and inflammation in subjects with metabolic syndrome

   • Silvio Buscemi
   • Salvatore Verga
   • Giovanni Cerasola

   Original Article 26 September 2008 Pages: 55 - 61

   

9. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan

   • Okan Bakiner
   • Melek E. Ertorer
   • Nilgun G. Demirag

   Original Article 30 September 2008 Pages: 63 - 65

10. Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study

    • G. De Mattia
    • O. Laurenti
    • A. Moretti

    Original Article Open access 22 November 2008 Pages: 67 - 73

    

11. Pioglitazone reduces monocyte activation in type 2 diabetes

    • Dario Pitocco
    • Simona Giubilato
    • Giovanni Ghirlanda

    Short Communication 27 September 2008 Pages: 75 - 77